United Therapeutics Corporation

Equities

UTHR

US91307C1027

Market Closed - Nasdaq Other stock markets 21:00:00 16/01/2026 GMT			5-day change	1st Jan Change
464.93 ^USD	-1.50%		-3.79%	-4.58%

01-15	United Therapeutics Insider Sold Shares Worth $3,900,122, According to a Recent SEC Filing	MT
01-12	United Therapeutics Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 01:30 PM

Transcript : United Therapeutics Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 12

Published on 03/05/2024 at 05:50 pm GMT

S&P Capital IQ

Presenter Speech
Joseph Thome (Analysts)

44th Annual TD Cowen Healthcare Conference. I'm Joe Thome, I'm one of the senior biotech analyst here on the team at TD Cowen. And it's my pleasure to have with

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about United Therapeutics Corporation

01-15	United Therapeutics Insider Sold Shares Worth $3,900,122, According to a Recent SEC Filing	MT
01-12	United Therapeutics Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 01:30 PM
01-07	SAB Biotherapeutics, Inc. Announces Board Changes ,Effective January 7, 2026	CI
01-06	UBS Adjusts Price Target on United Therapeutics to $645 From $600, Maintains Buy Rating	MT
01-05	United Therapeutics Insider Sold Shares Worth $500,015, According to a Recent SEC Filing	MT
12-29	United Therapeutics Insider Sold Shares Worth $11,572,963, According to a Recent SEC Filing	MT
12-29	United Therapeutics Insider Sold Shares Worth $5,644,954, According to a Recent SEC Filing	MT
12-23	United Therapeutics Insider Sold Shares Worth $3,047,201, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $3,952,689, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $1,742,193, According to a Recent SEC Filing	MT
12-16	United Therapeutics Insider Sold Shares Worth $11,166,722, According to a Recent SEC Filing	MT
12-10	United Therapeutics Insider Sold Shares Worth $3,833,374, According to a Recent SEC Filing	MT
12-09	United Therapeutics Insider Sold Shares Worth $10,050,597, According to a Recent SEC Filing	MT
12-08	United Therapeutics Insider Sold Shares Worth $3,870,056, According to a Recent SEC Filing	MT
12-05	United Therapeutics Insider Sold Shares Worth $3,821,130, According to a Recent SEC Filing	MT
12-02	United Therapeutics Insider Sold Shares Worth $10,798,079, According to a Recent SEC Filing	MT
12-02	United Therapeutics Insider Sold Shares Worth $3,852,846, According to a Recent SEC Filing	MT
12-02	United Therapeutics Insider Sold Shares Worth $10,079,696, According to a Recent SEC Filing	MT
11-25	United Therapeutics Insider Sold Shares Worth $3,784,419, According to a Recent SEC Filing	MT
11-21	United Therapeutics Insider Sold Shares Worth $3,812,082, According to a Recent SEC Filing	MT
11-20	United Therapeutics Insider Sold Shares Worth $3,789,373, According to a Recent SEC Filing	MT
11-18	United Therapeutics Corporation Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 12:00 PM
11-14	United Therapeutics Insider Sold Shares Worth $4,755,854, According to a Recent SEC Filing	MT
11-13	United Therapeutics Insider Sold Shares Worth $5,112,335, According to a Recent SEC Filing	MT
11-12	United Therapeutics Insider Sold Shares Worth $3,600,830, According to a Recent SEC Filing	MT